Vita Nova Supra SA
7.3 FTEVita Nova Supra reported total assets of €1.80m at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Aug 2026), with 7.3 full-time equivalents.
By total assets for 2025, Vita Nova Supra ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Vita Nova Supra shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +167 % Total assets +81 % Headcount (avg FTE) +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vita Nova Supra's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 04 Aug 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 01 Aug 2023
- Year ended 31 Dec 2021filed on 17 Jun 2022
Vita Nova Supra's financial analysis
- Solvency62.3%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vita Nova Supra
Vita Nova Supra's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0836.699.531
- VAT number
- BE0836699531
- Peppol
- Registered · 0208:0836699531 · as of 12 Nov 2026
- Legal form
- SA
- Incorporated
- 27 May 2011
- Registered office
- 3580 Beringen
- Size
- Micro · 7.3 FTE
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Vita Nova Supra (SA) has been based in Beringen since 2011, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 258,949 € and equity of €1.12m; its revenue is not published. With 7.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 62.3%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Vita Nova Supra
Companies in the same business, of comparable size and area, outside its group.
- De Ceunynck Radiotherapy Manufacture of pharmaceutical preparations Aartselaar · balance sheet 477,215 €
- Devyser Manufacture of irradiation, electromedical and electrotherapeutic equipment Brussels · balance sheet 449,972 €
- Concept Dental AL Installation of industrial machinery and equipment Remicourt · balance sheet €1.10m
- Demant Belgium Manufacture of irradiation, electromedical and electrotherapeutic equipment Leuven · balance sheet €8.81m
- Beun - de Ronde - Serlabo Manufacture of medical and dental instruments and supplies Beersel · balance sheet €3.98m
- Myocene Manufacture of irradiation, electromedical and electrotherapeutic equipment Liège · balance sheet €3.51m
- Uplifted Wholesale of pharmaceutical and medical goods Beringen · balance sheet 585,394 €
- Cepheid Benelux Manufacture of communication equipment Ghent · balance sheet €10.7m
Frequently asked questions about Vita Nova Supra
What is the revenue of Vita Nova Supra?
Vita Nova Supra files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vita Nova Supra?
In Belgium, the VAT number is the company number prefixed with BE: BE0836699531 for Vita Nova Supra, if the company is VAT-registered. Its company number (CBE) is 0836.699.531.
Where is the registered office of Vita Nova Supra?
According to the CBE register, the registered office of Vita Nova Supra is in 3580 Beringen.
What is the equity of Vita Nova Supra?
At the close of the 2025 financial year, the equity of Vita Nova Supra amounts to 1,123,140 €, a solvency of 62.3% of total assets.
How many people work at Vita Nova Supra?
7.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Vita Nova Supra?
The register lists 2 active mandates at Vita Nova Supra. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Vita Nova Supra within its sector?
By total assets for 2025, Vita Nova Supra ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Vita Nova Supra
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →